The increasing involvement of private equity firms in the methadone treatment industry is spotlighted in STAT's investigative series, 'War on Recovery'. The series, particularly its third part, delves into how these firms have acquired stakes in nearly one-third of all U.S. methadone clinics, totaling 562 clinics, in recent years. This consolidation has sparked a contentious debate over access to addiction medications, with private equity-backed clinics lobbying to maintain their exclusive rights to dispense methadone. Senator Ed Markey highlighted the divide, stating, "We have the physicians of America on our side, and they have the MBAs of America on their side," showcasing the opposition to easier drug access. The series by Lev Facher uncovers the potential implications of this monopoly, including the efforts to block reforms that would facilitate easier access to methadone for those in need.
Addiction expert Mark Parrino explains how private equity became involved with methadone clinics and the potential problems in new Q/A with STAT's Lev Facher. Read: https://t.co/Zu0QulLN6j https://t.co/lhFfQgf6LD
The methadone clinic monopoly: Opioid treatment chains backed by private equity are fighting calls for reform https://t.co/xPINCvAFxt
Private equity firms have acquired stakes in nearly one-third of all methadone clinics in the U.S. in recent years. Experts say the firms are investing with the expectation that the clinics will increase in value. Read Part 3 of The War on Recovery: https://t.co/IHGaojrvSK https://t.co/vPOxUfZL0c
A handful of financial institutions now has an ownership stake in 562 methadone clinics in the US, according to a STAT analysis. And, PE-backed clinics are lobbying to preserve exclusive right to dispense methadone, @statnews' Lev Facher reports: https://t.co/84UUP6e6kJ
STAT first-of-its-kind analysis found that private equity firms have acquired stakes in nearly one-third of all methadone clinics. Part 3 of the the War on Recovery investigative series. https://t.co/9FzSrPE6U9 via @statnews
The methadone clinic monopoly: Opioid treatment chains backed by private equity are fighting calls for reform Part 3 from Lev Facher's War on Recovery https://t.co/pO4jteACkd
Private equity firms have ownership stakes in about a third of US methadone clinics & they are lobbying to block easier access to the drug. Sen. Ed Markey: “We have the physicians of America on our side, and they have the MBAs of America on their side."🔒 https://t.co/NLDsDynBdW
Part 3 of STAT's "War on Recovery" series by Lev Facher. The methadone clinic monopoly: Opioid treatment chains backed by private equity are fighting calls for reform Private equity firms have acquired stakes in nearly one-third of all methadone clinics in recent years,…
Private equity’s surging interest in the methadone treatment industry adds a new layer to the fraught and fast-shifting debate over access to addiction medications. https://t.co/zKdmmkk9q0